Showing results (1061-1070 of 10,077) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|September 10, 2011
Promising pharmacological, molecular and cellular treatments of autoimmune hepatitisAlbert J CzajaCurrent Pharmaceutical Design|September 10, 2011
Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatmentJia Yao, Roberta Diaz BrintonCurrent Pharmaceutical Design|September 10, 2011
Therapeutic intervention at cellular quality control systems in Alzheimer's and Parkinson's diseasesDaniela M Arduino, A Raquel Esteves, Diana F F Silva, et al.Current Pharmaceutical Design|September 10, 2011
Microtubules (tau) as an emerging therapeutic target: NAP (davunetide)Illana GozesCurrent Pharmaceutical Design|September 10, 2011
The mitochondrial dynamics of Alzheimer's disease and Parkinson's disease offer important opportunities for therapeutic interventionDavid J Bonda, Mark A Smith, George Perry, et al.Current Pharmaceutical Design|August 13, 2011
Cytokine signaling modulates blood-brain barrier functionWeihong Pan, Kirsten P Stone, Hung Hsuchou, et al.Current Pharmaceutical Design|September 17, 2011
The future of induced pluripotent stem cells for cardiac therapy and drug developmentLieven Thorrez, Maurilio SampaolesiCurrent Pharmaceutical Design|September 17, 2011
Cardiac cell therapy and bypass surgeryYeong-Hoon Choi, Boris Nasseri, Christof StammCurrent Pharmaceutical Design|February 23, 2012
Clinical applications and biosafety of human adult mesenchymal stem cellsE Mariani, A FacchiniCurrent Pharmaceutical Design|February 23, 2012
Role of miRNAs in muscle stem cell biology: proliferation, differentiation and deathStefania Crippa, Marco Cassano, Maurilio SampaolesiPageof 1,008